Her er en liste på noen av de som deltok:
-Peter Andrew McCullough
was born in
Buffalo, New York, on December 29, 1962.
[7] He earned a Bachelor of Science degree from
Baylor University in 1984 and his
Doctor of Medicine (MD) degree from the
University of Texas Southwestern Medical Center in 1988.
[8] He completed his residency in internal medicine at the
University of Washington in Seattle, a cardiology fellowship in 1991, and practiced internal medicine in
Grayling, Michigan, for two years before enrolling in the
University of Michigan School of Public Health, earning a
Master of Public Health (MPH) degree in 1994.
-Pierre Kory
In 2002, Kory graduated from
St. George's University in
Grenada,
West Indies, with a Doctor of Medicine (MD) degree and completed
residency and
fellowship training in
critical care and
pulmonary medicine.
[5] He did
clinical rotations at the
Weill Cornell School of Medicine.
[5] Kory first practiced in
Madison, Wisconsin, at
UW Health, which is the
academic medical center at the
University of Wisconsin. He served there as the
medical director for the Trauma and Life Support Center, in the outpatient pulmonary medicine clinic, where he performed
bronchoscopic and
pleural procedures.
[5] Kory was the critical care service chief at the
UW Health University Hospital (part of the
University of Wisconsin School of Medicine and Public Health) until May 2020.
[6][7] He later joined
Aurora St. Luke's Medical Center in
Milwaukee, Wisconsin,
[8] before becoming a
locum tenens physician.
[9]
Kory is an expert in critical care
ultrasonography. In 2015, along with his two co-editors, Kory won the
British Medical Association's 2015 President’s Choice award in medical textbooks for their work on
Point of Care Ultrasound.
[5]
Harvey A. Risch, MD, PhD
Professor of Epidemiology, Yale School of Public Health, Yale Cancer Center - Cited by 55,906 - Cancer epidemiology--etiology and prevention - Medicines and cancer - Epidemiologic methods - Legal consulting - Expert work-product
scholar.google.com
Harvey Risch is Professor Emeritus of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. Dr. Risch received his MD degree from the University of California San Diego and PhD, in mathematical modeling of infectious epidemics, from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Dr. Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale. Dr. Risch's research interests are in the areas of cancer etiology, prevention and early diagnosis, and in epidemiologic methods. He is especially interested in the effects of reproductive factors, diet, genetic predisposition, histopathologic factors, occupational/environmental/medication exposures, infection and immune functioning in cancer etiology. His major research projects have included studies of ovarian cancer, pancreas cancer, lung cancer, bladder cancer, esophageal and stomach cancer, and of cancers related to usage of oral contraceptives and noncontraceptive estrogens. Dr. Risch is Associate Editor of the
Journal of the National Cancer Institute, Editor of the
International Journal of Cancer, and for six years was a Member of the Board of Editors, the
American Journal of Epidemiology. Dr. Risch is an author of more than 400 original peer-reviewed research publications in the medical literature and those research papers have been cited by other scientific publications more than 47,000 times. Dr. Risch has an h-index of 103 and is a Member of the Connecticut Academy of Sciences and Engineering.
Robert W. Malone
In the late 1980s, while a graduate student researcher at the
Salk Institute for Biological Studies in
San Diego,
California, Malone conducted studies on messenger ribonucleic acid (
mRNA) technology, discovering in what
Nature has described as a landmark experiment that it was possible to transfer mRNA protected by a
liposome into cultured cells to signal the information needed for the production of proteins.
[3][13][4] With
Philip Felgner, he performed experiments on the
transfection of RNA into human, rat, mouse,
Xenopus, and
Drosophila cells, work which was published in 1989.
[3][14] In 1990, he contributed to a paper with
Jon A. Wolff,
Dennis A. Carson, and others, which first suggested the possibility of synthesizing mRNA in a laboratory to trigger the production of a desired protein.
[15] These studies are recognized as among the earliest steps towards
mRNA vaccine development.
[3][16][17][18]
While Malone promotes himself as an inventor of mRNA vaccines,
[1][7] credit for the distinction is more often given to the lead authors on the major papers he contributed to (such as Felgner and Wolff), later advances by
Katalin Karikó and
Drew Weissman,
[3][19] or
Moderna co-founder
Derrick Rossi.
[13] Ultimately, mRNA vaccines were the decades-long result of the contributions of hundreds of researchers, including Malone.
[3][20] The New York Times, in an article about Malone, reported: "While he was involved in some early research into the technology, his role in its creation was minimal at best, say half a dozen Covid experts and researchers, including three who worked closely with Dr. Malone."
[7]
Malone has served as director of clinical affairs for Avancer Group, assistant professor at the
University of Maryland, Baltimore school of medicine, and an adjunct associate professor of
biotechnology at
Kennesaw State University.
[21] He was CEO and co-founder of Atheric Pharmaceutical,
[22] which in 2016 was contracted by the
U.S. Army Medical Research Institute of Infectious Diseases to assist in the development of a treatment for the
Zika virus by evaluating the efficacy of existing drugs.
[23][24][25][26] Until 2020, Malone was chief medical officer at Alchem Laboratories, a Florida pharmaceutical company.
[27] He has claimed he helped secure early-stage approval for research by
Merck & Co. on an
Ebola vaccine, in the mid-2010s.
[7]
Edward Dowd, former Advisor to the FDA Commissioner
David Gortler, PharmD,
Former YSM assistant professor of pharmacology David Gortler takes the mission of ensuring drug safety very seriously.
medicine.yale.edu
Og endel flere
Dette er folk med mye utdanning og lang erfaring, jeg syns det er tåpelig å forkaste det de sier som bs sånn uten videre.
I tillegg var det andre folk der som ikke var leger, men feks advokater etc
Felles for alle var at de har vær kritiske til mye av det som har foregått og dermed blitt kastet under bussen.
At man holder på slik syns jeg ikke noe om, når man varsler fortjener man å bli tatt seriøst og vernet om som en varsler.
Dette er spesielt viktig i tilfeller som dette, der utrulling av en vaksine (som er ny og ikke utprøvd teknologi) til hele verdens befolkning krever at vi er ekstra forsiktige.
Dersom det er et snev av usikkerhet, eller at noen varsler, burde ting settes på hold og undersøkes.